Search hospitals > North Carolina > Greensboro
Medication Management, LLC
Claim this profileGreensboro, North Carolina 27408
Global Leader in Subtalar Arthritis
Global Leader in Rheumatoid Arthritis
Conducts research for Systemic Lupus Erythematosus
Conducts research for Cardiovascular Disease
Conducts research for Diabetes Mellitus
65 reported clinical trials
5 medical researchers
Summary
Medication Management, LLC is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Subtalar Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Cardiovascular Disease, Diabetes Mellitus and other specialties. Medication Management, LLC is involved with conducting 65 clinical trials across 94 conditions. There are 5 research doctors associated with this hospital, such as Jagadeesh Ganji, Walter Pharr, MD, Tauseef G Syed, and James Donald Franklin.Top PIs
Jagadeesh GanjiMedication Management4 years of reported clinical research
Studies Cardiovascular Disease
Studies Congestive Heart Failure
4 reported clinical trials
5 drugs studied
Walter Pharr, MDMedication Management4 years of reported clinical research
Studies Dermatitis and Eczema
Studies Atopic Dermatitis
3 reported clinical trials
4 drugs studied
Tauseef G SyedMedication Management5 years of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
3 reported clinical trials
7 drugs studied
James Donald FranklinMedication Management3 years of reported clinical research
Studies Alzheimer's Disease
Studies Obesity
2 reported clinical trials
2 drugs studied
Clinical Trials running at Medication Management, LLC
Obesity
Systemic Lupus Erythematosus
Cardiovascular Disease
Heart Failure
Atherosclerosis
Alzheimer's Disease
Cutaneous Lupus Erythematosus
Childhood Obesity
Elevated Lipoprotein
Kidney Disorders
LY3841136 + Tirzepatide
for Obesity with Type 2 Diabetes
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes. Participation in the study will last about 64 weeks.
Recruiting0 awards Phase 2
PF-07081532 + Rybelsus
for Type 2 Diabetes and PF-07081532
This trial is testing a new drug called PF-07081532 to see if it can help people lose weight or control their blood sugar. The study includes obese individuals without diabetes and diabetic patients already taking metformin. Participants will receive either the new drug or an approved treatment and will be monitored over time.
Recruiting0 awards Phase 24 criteria
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Recruiting0 awards Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Medication Management, LLC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.